The FDA announced Tuesday that it will allow the maker of ZYN nicotine pouches to advertise some of its products as safer to ...
The Food and Drug Administration will allow Philip Morris International to market Zyn nicotine pouches as presenting a lower ...
The maker of ZYN nicotine pouches can tell consumers its products are safer to use than cigarettes, the Food and Drug ...
ZYN nicotine pouches can now be marketed as less harmful to human health than cigarettes, the U.S. Food and Drug ...
The U.S. Food and Drug Administration (FDA) has authorized marketing of 20 ZYN nicotine pouch products as a lower-risk option ...
The FDA granted modified risk orders for 20 ZYN nicotine pouch products, allowing them to be marketed with the claim that switching completely from cigarettes to ZYN lowers the risk of several smoking ...
The FDA has concluded that “Swedish Match had demonstrated that the specific modified risk claim is scientifically accurate ...
The FDA’s action highlights a stark contrast: in the U.S., nicotine products undergo detailed scientific review before being authorized, while in many countries policymakers opt for bans rather than ...
In a significant regulatory decision for the tobacco harm reduction industry, the US Food and Drug Administration (FDA) has ...
Zyn nicotine pouch products. Stamford, Connecticut-based Philip Morris International Inc. (PMI), which owns Swedish Match, ...
Nicotine pouch sales are projected to increase to more than $40 billion worldwide by 2033 from $6.9 billion in 2025, one ...
FDA has allowed the maker of ZYN, a popular nicotine pouch brand, to market its products as "less harmful" than cigarettes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results